Regenerative Medical Technology Group Inc.
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equip… Read more
Market Cap & Net Worth: Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (PINK:RMTG) has a market capitalization of $420.45K ($420.45K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38078 globally and #12401 in its home market, demonstrating a 2.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Regenerative Medical Technology Group Inc.'s stock price $0.03 by its total outstanding shares 13138968 (13.14 Million).
Regenerative Medical Technology Group Inc. Market Cap History: 2015 to 2025
Regenerative Medical Technology Group Inc.'s market capitalization history from 2015 to 2025. Data shows change from $5.26 Million to $420.45K (-25.21% CAGR).
Regenerative Medical Technology Group Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Regenerative Medical Technology Group Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Regenerative Medical Technology Group Inc.'s market cap is 0.09 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.26 Million | $5.41K | -$1.93 Million | 971.10x | N/A |
| 2017 | $1.31 Million | $29.24K | -$377.01K | 44.93x | N/A |
| 2018 | $641.18K | $50.12K | -$2.06 Million | 12.79x | N/A |
| 2020 | $420.45K | $55.08K | -$5.90 Million | 7.63x | N/A |
| 2021 | $3.55 Million | $437.89K | -$12.88 Million | 8.10x | N/A |
| 2022 | $249.64K | $1.53 Million | -$5.49 Million | 0.16x | N/A |
| 2023 | $95.91K | $2.41 Million | -$9.81 Million | 0.04x | N/A |
| 2024 | $381.03K | $4.11 Million | -$5.56 Million | 0.09x | N/A |
Competitor Companies of RMTG by Market Capitalization
Companies near Regenerative Medical Technology Group Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Regenerative Medical Technology Group Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Regenerative Medical Technology Group Inc. Historical Marketcap From 2015 to 2025
Between 2015 and today, Regenerative Medical Technology Group Inc.'s market cap moved from $5.26 Million to $ 420.45K, with a yearly change of -25.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $420.45K | +10.34% |
| 2024 | $381.03K | +297.26% |
| 2023 | $95.91K | -61.58% |
| 2022 | $249.64K | -92.96% |
| 2021 | $3.55 Million | +743.75% |
| 2020 | $420.45K | +63.27% |
| 2019 | $257.52K | -59.84% |
| 2018 | $641.18K | -51.20% |
| 2017 | $1.31 Million | -60.00% |
| 2016 | $3.28 Million | -37.50% |
| 2015 | $5.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Regenerative Medical Technology Group Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $420.45K USD |
| MoneyControl | $420.45K USD |
| MarketWatch | $420.45K USD |
| marketcap.company | $420.45K USD |
| Reuters | $420.45K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.